NeuroThera Labs acquires 54% stake in CliniQuantum for CAD$9.5 million
SciSparc Ltd. (NASDAQ: SPRC) announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) completed the acquisition of approximately 54% of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
